RH Managers
Private equityJohannesburg · Seed–Late Stage · 14 people tracked
Find your way into RH Managers
Sign up to see every warm intro you have to RH Managers
- Paths you didn't know you had: your email and LinkedIn already hold routes to the RH Managers team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
RH Managers follows a thesis-driven investment strategy that pairs extensive research with deep industry knowledge and local market experience in healthcare and impact investing across Africa. The firm invests through private equity in healthcare infrastructure aimed at broadening access to quality healthcare for South Africans. It supports companies across all development stages and takes a long-term view, aligning the interests of portfolio company management teams, limited partners, and the firm's professionals. Operating as an integrated private partnership, it commits its full resources to the success of its portfolio companies.
Source: firm website, verified Aug 3, 2026.
Team · 14 people
from the firm's websiteFrequently asked questions
- What stage does RH Managers invest at?
- RH Managers invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does RH Managers focus on?
- RH Managers focuses on Healthtech, Impact & Social Good.
- Where is RH Managers located?
- RH Managers is headquartered in Johannesburg, ZA.
Media · Podcasts & interviews
featuring the teamNHI Bill I Quinton Zunga, CEO of RH Managers reacts
SABC News · Quinton Zunga
Images
Similar investors
MPM BioImpact combines 30+ years of biotech venture capital expertise with impact investing and public market experience, managing early-stage venture funds, private/public impact funds, and a public equities fund focused on transforming patient outcomes.
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.
Obvious is a venture capital firm focused on supporting founders building solutions to humanity's largest challenges across planetary health, human health, and economic health.
Forbion is a global venture capital firm focused on advancing biotech innovations and other sustainable solutions aimed at improving human and planetary health.
Gilde Healthcare is a specialist investment firm managing healthcare and climate-focused funds across venture & growth, and private equity strategies with a transatlantic team of sector specialists.



















